F Pezzella
Overview
Explore the profile of F Pezzella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
2424
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pezzella F, Harris A, Tavassoli M, Gatter K
Cell Death Discov
. 2016 Aug;
1:15064.
PMID: 27551488
No abstract available.
2.
Donnem T, Kilvaer T, Andersen S, Richardsen E, Paulsen E, Hald S, et al.
Ann Oncol
. 2015 Nov;
27(2):225-32.
PMID: 26578726
Immunoscore is a prognostic tool defined to quantify in situ immune cell infiltrates and appears highly promising as a supplement to the tumor-node-metastasis (TNM) classification of various tumors. In colorectal...
3.
Kashima T, Turley H, Dongre A, Pezzella F, Athanasou N
Virchows Arch
. 2013 Mar;
462(4):465-72.
PMID: 23511993
Adipocyte P2 (aP2), also known as fatty acid-binding protein 4 (FABP4), is a fatty acid-binding protein found in the cytoplasm of cells of adipocyte differentiation. In this study, we examined...
4.
Jubb A, Cesario A, Ferguson M, Congedo M, Gatter K, Lococo F, et al.
Br J Cancer
. 2011 May;
104(12):1877-81.
PMID: 21540863
Background: Anti-angiogenic therapy with bevacizumab (an anti-vascular endothelial growth factor (VEGF) antibody) predominantly targets immature blood vessels. Bevacizumab has shown a survival benefit in non-small cell lung carcinoma (NSCLC) and...
5.
Jubb A, Turley H, Moeller H, Steers G, Han C, Li J, et al.
Br J Cancer
. 2009 Oct;
101(10):1749-57.
PMID: 19844231
Background: Delta-like ligand 4 (Dll4) is a Notch ligand that is upregulated by hypoxia and vascular endothelial growth factor-A (VEGF-A) and is reported to have a role in tumor angiogenesis....
6.
Tan E, Yan M, Campo L, Han C, Takano E, Turley H, et al.
Br J Cancer
. 2009 Jan;
100(2):405-11.
PMID: 19165203
Basal-like tumours account for 15% of invasive breast carcinomas and are associated with a poorer prognosis and resistance to therapy. We hypothesised that this aggressive phenotype is because of an...
7.
Lawrie C, Shilling R, Troussard X, Cattan H, Mossafa H, Pezzella F, et al.
Leukemia
. 2008 Aug;
23(3):581-3.
PMID: 18754033
No abstract available.
8.
Lawrie C, Saunders N, Soneji S, Palazzo S, Dunlop H, Cooper C, et al.
Leukemia
. 2008 Jan;
22(7):1440-6.
PMID: 18185523
No abstract available.
9.
Borenstein J, Pezzella F, Gatter K
Histopathology
. 2007 Oct;
51(6):774-7.
PMID: 17944927
Aims: To describe four cases of plasmablastic lymphoma arising in the unusual setting of a post-transplantation lymphoproliferative disorder (PTLD). Methods And Results: Four cases were encountered over 2 years in...
10.
Kato T, Steers G, Campo L, Roberts H, Leek R, Turley H, et al.
Br J Cancer
. 2007 Oct;
97(9):1277-86.
PMID: 17923874
The purpose of this study is to investigate the associations of microvessel density (MVD) and other pathological variables with survival, and whether they accounted for survival differences between Japanese and...